Twiga Chemical Industries was incorporated on 18th May 1949, then referred to as AECI (EA) Ltd. It was a subsidiary of Imperial Chemical Industries PLC (ICI),UK. By a Special Resolution passed on the 1st July 1962, the company was renamed ‘Twiga Chemical Industries Limited'. The Company engaged in the supply and distribution of Explosives, Agrochemicals, Industrial Chemicals and Pharmaceuticals. Some of the Agrochemicals were locally formulated or repacked in the Company’s Factory in Industrial Area, Nairobi. In 1993, the AJ Group bought the controlling interest from ICI. In 2000, Animal Health Division was introduced with the intention of tapping the potential in this sector. The Division has expanded over the years. In 2004, the company discontinued the Pharmaceuticals Division. In 2006 the company implemented an ERP system ( Oracle E-Business Suite) covering the entire business operations of the company. In 2008 the company completed a major modernization programme at the Toll Manufacturing Centre that involved laying of new roads, purchase of new powder and liquid filling machines and pollution control equipments. The laboratory acquired a new High Performance Liquid Chromatograph. In 2009 the entire company was certified ISO 9001:2008. The Company is managed by a team of experienced qualified professionals in each of its areas of business.

Wide Spectrum Enterprises (U) Ltd is a private limited company that operates under certificate of incorporation No. 55848 issued 10/2002 by the registrar of companies of the Ugandan Government as importer and distributor of pharmaceuticals drugs on wholesale basis. We aim to become the biggest and most profitable pharmaceutical distribution company in Uganda.  Activities To build strong relationships with key stake holders in the pharmaceutical sector including but not limited to doctors, pharmacists, nurses, NDA and PSU. To offer a conducive working environment to our employees. To hire qualified professionals and offer them opportunities of continuous training. To register, import and distribute a variety of trusted branded and generic specialist oriented products from the Middle East and Europe. To distribute pharmaceuticals to private hospitals, clinics, medical centers, NMS, JMS and other pharmacies. To comply with NDA, PSU, NEMA guidelines and other laws governing pharmaceuticals in Uganda. Distributor in Uganda Wide Spectrum Enterprises (U) Ltd is an importer and distributor of many international pharmaceutical manufacturers like: Al Andalous - Egypt Amoun - Egypt API - Jordan EIPICO - Egypt Eva - Egypt Global Napi- Egypt Macro- Egypt

Akim Dental Service is a private dental clinic in Dar es Salaam located at Samora Avenue NHC - House 9th floor, offering various dental services to different customers with various dental needs. The clinic is owned and run by Dr. Joakim Michael Kifai since July 1994 when it was first established. The market for provision of quality dental care in Tanzania is growing fast and Akim Dental Service envisages a great potential for expansion of its service to meet the growing need for quality dental care in Tanzanian society. Our objective is to be prime dental health care provider in Tanzania. Currently our clinic is offering various dental services to both adult and children with treatment based on individual need and requirements. Service offered includes restorative dentistry, endodontics, prosthodontics, orthodontics, periodontology, oral surgery and cosmetic dentistry. Our immediate plans is to incorporate more specialized services like implantology and laser dentistry as well as clinical training for newly graduate dentists, assistant dental officers and dental technician who wants to improve their clinical skills and experience in modern dentistry. Besides providing services to the residents of Dar es Salaam, and other parts of Tanzania we are treating patient from Comoro, Democratic Republic of Congo, Zambia, Malawi as well. Our long term objective is centered on establishing dental franchise which will offer high quality dental services to Tanzania society and neighboring countries. SERVICES Dental Diagnosis Fillings Scaling & Polishing Dentures Tooth Extraction Wisdom Tooth Removal Tooth Whitetenings Dental Crowns Dental Veneers Onlays & Inlays Paedodontics Restorative Dentistry Preventive Dentistry Ceramic Laboratory Dental Bonding Preventive Dentistry Partial Denture Full Denture Crowns Bridges Sealants Bridges Endodontics We are located at Samora Avenue NHC - House 9th Floor. The building is adjacent to X Telecom building and opposite Twiga Bank. Call for your appointment we are open throughout the day Monday to Saturday from 8:00 AM to 5:00 PM. We accept Strategis Insurance card. Visit us today for any of your dental treatment or need.

AFA Pharmaceuticals Laboratories (Private) Limited is a Private Limited Company, founded in 1973, by its present Chairman and Chief Executive, Mr. Muhammad Amin Khan. Our founder firmly believes in the theory of "MEDICINES FOR ALL", which plays a key role in setting up the prices of our new introductions in the market. Our motto is "NOBODY SHOULD SUFFER FROM WANT OF MEDICATION"ZAFA is the 1st Pakistan based Multinational Pharmaceutical manufacturing concern with its own manufacturing facility based in Khartoum Sudan. In addition to this we have presence in various African, Middle Eastern and South American countries. We are an ISO 9001:2000 certified manufacturing concern and has emerged as a leading Pharmaceutical Group of Companies that has brought the concept of Dedicated Manufacturing facilities in Pakistan. We are proud to be the 1st Pakistan BasedMultinational Pharmaceutical Manufacturing concern with our own operational l facilities in Khartoum, Sudan. We are presently ranked at #2 (we sell above 60 million unit packs per annum) in Pakistan as per Unit Wise sales and are operating with Nine (9) manufacturingfacilities and two (2) to be commissioned soon. All these facilities are Pharmaceutical l facilities. In addition there is one more facility for printing and packaging material. We started our manufacturing and marketing operations with anti-inflammatory and potassium supplements besides iron preparations. Today ZAFA product range represents a wide category of therapeutic classes and we are one of the few companies in the world to manufacture Insulin formulations (both Hunman and Bovine). Our present product range includes above 300 products with another 30 in the pipeline, 13 of our products are leaders in Pakistan as per Unit Wise sales. ZAFA is an equal opportunity employer and employs a staff of around 3000 with around 50% being females. ZAFA has one of the largest manufacturing facilities in Pakistan with total covered area of over 500,000 square feet. We firmly believe that only professional people can run a progressive organization and implement its believes and philosophies. Our employees are one of our most important assets and carefully tailored training programs are run round the year for updating their knowledge and skills. In addition to Quality Control facilities at each of our units, we have a fully equipped Central Quality Assurance/Control Laboratory to monitor Quality at all our facilities. 1200 Quality system documents have been developed and implemented to streamline different processes and an effective command and control system is present to ensure consistency and reproducibility. All Quality records are indexed and filed in such a way to ensure easy and quick retrieval of records to show objective evidence of the effective operations of the company and compliance to our products. The management has developed an internal quality audit plan to check the effectiveness of the command and control system and a cross facility team has been developed and trained to perform independent audits of different facilities within the group. All this done in line with our prime policy statement of "ensuring the availability of Quality drugs at Affordable prices throughout the country and world".

Elite Pharmaceuticals, Inc. is a specialty pharmaceutical company developing a pipeline of proprietary pharmacological abuse-deterrent opioid products and niche generic products. Elite specializes in oral sustained and controlled release drug products with high barriers to entry. Elite has eight commercial products currently being sold, several additional approved products pending manufacturing site transfer and an additional product under review pending approval by the FDA. Elite's lead pipeline products include abuse-deterrent opioids utilizing the Company's patented proprietary technology, and a once-daily opioid. They are sustained release oral formulations of opioids for the treatment of chronic pain, which address two of the limitations of existing oral opioids: the provision of consistent relief of baseline pain levels and deterrence of potential abuse. Elite also provides contract manufacturing for Ascend Laboratories (a subsidiary of Alkem Laboratories Ltd.) and has partnered with Epic Pharma for the manufacturing and distribution of eleven approved products pending manufacturing site transfer, with Akorn, Inc. to develop an intermediate for a generic product, and a Hong Kong based company to develop a branded product for the United States market and its territories. Elite operates a cGMP and DEA registered facility for research, development, and manufacturing located in Northvale, NJ. ELITE PHARMACEUTICALS is a specialty pharmaceutical company specializing in niche generics and committed to the development of abuse-deterrent opioids to help curb diversion, misuse and abuse. Elite has a pipeline of opioid abuse-deterrent products under development utilizing the company’s proprietary pharmacological abuse-deterrent technology. This platform technology works with all opioids. Elite Pharmaceuticals, Inc. is a specialty pharmaceutical company developing a pipeline of proprietary pharmacological abuse-deterrent opioid products and niche generic products. Elite specializes in oral sustained and controlled release drug products with high barriers to entry. Elite owns generic which have been licensed to TAGI Pharma and Glenmark Pharmaceuticals Inc., USA. Elite currently has twelve approved generic products, four generic products filed with the FDA, two approved products pending manufacturing site transfer, and the NDA filing for SequestOx™. Elite’s pipeline products include abuse-deterrent opioids which utilize the Company’s patented proprietary technology and a once-daily opioid.  These products include sustained release oral formulations of opioids for the treatment of chronic pain. These formulations are intended to address two major limitations of existing oral opioids: the provision of consistent relief of baseline pain levels and deterrence of potential opioid abuse.